Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$74.6K Buy
25,536
+895
+4% +$2.56K 0.05% 137
2025
Q4
$60.9K Buy
24,641
+2,799
+13% +$6.67K 0.04% 143
2025
Q3
$48.7K Hold
21,842
0.03% 147
2025
Q2
$52.6K Sell
21,842
-2,848
-12% -$6.93K 0.04% 148
2025
Q1
$57.5K Buy
24,690
+6,114
+33% +$12.2K 0.04% 156
2024
Q4
$34.4K Buy
18,576
+2,382
+15% +$5.27K 0.02% 167
2024
Q3
$39.5K Hold
16,194
0.03% 170
2024
Q2
$33.2K Hold
16,194
0.02% 160
2024
Q1
$40.2K Buy
16,194
+979
+6% +$2.55K 0.03% 188
2023
Q4
$42.6K Buy
+15,215
New +$41.1K 0.03% 172

Other funds holding ABEV

Renasant Bank's ABEV Position: Q1 2026 in Review

Renasant Bank increased its Ambev (ABEV) stake by 3.6% in Q1 2026, buying an estimated $2.56K and bringing the position to 25,536 shares worth $74.6K. The position accounts for 0.05% of the portfolio, ranked #137.

Renasant Bank first reported a position in ABEV in Q4 2023 and has held it in 10 quarters since. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

  • Renasant Bank held 25,536 shares of Ambev worth $74.6K as of Q1 2026.
  • Renasant Bank bought 895 Ambev shares in Q1 2026, an estimated $2.56K.
  • Ambev made up 0.05% of Renasant Bank's portfolio in Q1 2026, its #137 holding.
  • Renasant Bank first reported a position in Ambev in Q4 2023 and has held it in 10 quarters since.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on Renasant Bank's 13F filing for Q1 2026, filed 29 Apr 2026.